Moderna’s Bancel steps down
Sales of Moderna’s COVID-19 shot exceeded expectations, but the company’s launch of its new RSV vaccine has started slowly.
Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...
While Moderna’s Spikevax beat Wall Street estimates in the third quarter, William Blair analyst Myles Minter in a Thursday ...
Investopedia on MSN1h
Moderna Stock Rises on Surprise Q3 ProfitModerna reported better third-quarter results than expected Thursday morning, as the vaccine maker reported a surprise profit ...
Moderna (NASDAQ:MRNA) has reported a surprise net income in the third quarter and announced changes at its leadership team, ...
He’s taking over a commercial assignment that was held by Stephane Bancel, who will remain chief executive officer. The ...
Moderna Inc.’s stock jumped 5% early Thursday, after the company’s third-quarter earnings showed an unexpected profit and ...
Dr. Loughlin will join the Executive Committee and report to Chief Executive Officer Stephane Bancel. Jacqueline Miller, M.D., has been promoted to Chief Medical Officer, and will lead Moderna’s ...
Moderna Chief Human Resources Officer Tracey Franklin has expanded her role to Chief People and Digital Technology Officer, overseeing the Company's talent and digital functions. Brad Miller, Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback